Although increased NO production through upregulation of iNOS is part of the intestinal antibacterial response, excess NO has been associated with intestinal inflammation in IBD patients and attributed to the immune dysregulation that occurs in these intestinal disorders (Kolios et al., 2004). This evidence concerns the gene NOS2 and inflammatory bowel disease.